Methods and implementation of a Hospital-Based Cancer Registry in a major city in a low-to middle-income country: the case of Cali, Colombia.

Autor: Parra-Lara LG; Centro de Investigaciones Clínicas (CIC), Fundación Valle del Lili, Cra 98 No. 18-49, 760032, Cali, Colombia. luis.parra@fvl.org.co.; Facultad de Ciencias de la Salud, Universidad Icesi, Calle 18 No. 122-135, 760031, Cali, Colombia. luis.parra@fvl.org.co., Mendoza-Urbano DM; Centro de Investigaciones Clínicas (CIC), Fundación Valle del Lili, Cra 98 No. 18-49, 760032, Cali, Colombia., Zambrano ÁR; Servicio de Hemato-Oncología, Departamento de Medicina Interna, Fundación Valle del Lili, Cra 98 No. 18-49, 760032, Cali, Colombia., Valencia-Orozco A; Centro de Investigaciones Clínicas (CIC), Fundación Valle del Lili, Cra 98 No. 18-49, 760032, Cali, Colombia., Bravo-Ocaña JC; Departamento de Patología y Laboratorio Clínico, Fundación Valle del Lili, Cra 98 No. 18-49, 760032, Cali, Colombia., Bravo-Ocaña LE; Registro Poblacional de Cáncer de Cali, Departamento de Patología, Facultad de Salud, Universidad del Valle, 760032, Cali, Colombia., Rosso F; Centro de Investigaciones Clínicas (CIC), Fundación Valle del Lili, Cra 98 No. 18-49, 760032, Cali, Colombia.; Facultad de Ciencias de la Salud, Universidad Icesi, Calle 18 No. 122-135, 760031, Cali, Colombia.; Servicio de Infectología, Departamento de Medicina Interna, Fundación Valle del Lili, Cra 98 No. 18-49, 760032, Cali, Colombia.
Jazyk: angličtina
Zdroj: Cancer causes & control : CCC [Cancer Causes Control] 2022 Mar; Vol. 33 (3), pp. 381-392. Date of Electronic Publication: 2022 Jan 11.
DOI: 10.1007/s10552-021-01532-z
Abstrakt: Purpose: To describe our experience upon developing and implementing a hospital-based cancer registry (HBCR) in a quaternary-level of care private non-profit academic medical center in Cali, Colombia.
Methods: HBCRs capture, in a given institution, every single patient with a confirmed malignancy. In this study, all cases evaluated between 2014 and 2018 were included in the HBCR. In compliance with the International Agency for Research on Cancer recommendations, cases were classified as analytic or non-analytic. Data derived from an exhaustive selection of patients was stored in a computing platform owned by the institution, meeting the 2016 Facility Oncology Registry Data Standards recommendations. Quality control was performed by evaluating comparability, timeliness, validity, and completeness.
Results: A total of 24,405 new cases were registered between 2014 and 2018, from which 4253 (17.4%) died. Among all cases, based on the anatomic location, most common malignancies were breast (n = 1554), thyroid (n = 1346), hematolymphoid (n = 1251), prostatic (n = 805), and colorectal (n = 624). The behavior of the new cases was consistent with an incremental trend.
Conclusion: Upon implementing the HBCR, major challenges were identified (i.e., a precise definition of cases, the development of processes for capturing new cases, a standardized data collection strategy, and carrying-out an appropriate patient follow-up). Based on our experience, the success of an HBCR largely relies on the interest from the institution, the engagement of stakeholders and financial support, that is, it depends on the adequate access over time to funding, technological, and staffing resources.
(© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)
Databáze: MEDLINE
Externí odkaz: